News | May 12, 2024
Novartis India posts Q4 FY24 net profit lower at Rs. 14.68 Cr
Novartis India has reported total income of Rs. 91.59 crores during the period ended March 31, 2024
Novartis India has reported total income of Rs. 91.59 crores during the period ended March 31, 2024
Novartis India has reported total income of Rs. 106.50 crores during the period ended December 31, 2023
Novartis India has reported total income of Rs. 147.44 crores during the period ended June 30, 2022.
Dr. Reddy’s to promote and distribute select Novartis products including the Voveran range, the Calcium range and Methergine in India
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)